skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Material Type:
Article 		Add to My Research

Dynamics of Neutralizing Antibody Titers in the Months After Severe Acute Respiratory Syndrome Coronavirus 2 Infection

The Journal of infectious diseases, 2021-02, Vol.223 (2), p.197-205 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. 2020 ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiaa618 ;PMID: 33535236

Full text available

Citations Cited by
2
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Material Type:
Article 		Add to My Research

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays

Viruses, 2020-05, Vol.12 (5), p.513 [Peer Reviewed Journal]

COPYRIGHT 2020 MDPI AG ;Attribution ;2020 by the authors. 2020 ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v12050513 ;PMID: 32384820

Full text available

Citations Cited by
3
Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak
Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak
Material Type:
Article 		Add to My Research

Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak

Nature communications, 2020-09, Vol.11 (1), p.4378-4378, Article 4378 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-18178-1 ;PMID: 32873791

Full text available

Citations Cited by
4
In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19
In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19
Material Type:
Article 		Add to My Research

In silico detection of SARS-CoV-2 specific B-cell epitopes and validation in ELISA for serological diagnosis of COVID-19

Scientific reports, 2021-02, Vol.11 (1), p.4290-4290, Article 4290 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-83730-y ;PMID: 33619344

Full text available

Citations Cited by
5
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice
Material Type:
Article 		Add to My Research

Adjuvanting a subunit SARS-CoV-2 vaccine with clinically relevant adjuvants induces durable protection in mice

npj vaccines, 2022-05, Vol.7 (1), p.55-55, Article 55 [Peer Reviewed Journal]

2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2059-0105 ;EISSN: 2059-0105 ;DOI: 10.1038/s41541-022-00472-2 ;PMID: 35606518

Full text available

Citations Cited by
6
Antigen spacing on protein nanoparticles influences antibody responses to vaccination
Antigen spacing on protein nanoparticles influences antibody responses to vaccination
Material Type:
Article 		Add to My Research

Antigen spacing on protein nanoparticles influences antibody responses to vaccination

Cell reports (Cambridge), 2023-12, Vol.42 (12), p.113552-113552, Article 113552 [Peer Reviewed Journal]

2023 The Authors ;Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2023.113552 ;PMID: 38096058

Full text available

Citations Cited by
7
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
Material Type:
Article 		Add to My Research

Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination

JCI insight, 2021-11, Vol.6 (22) [Peer Reviewed Journal]

2021 Cagigi et al. 2021 Cagigi et al. ;ISSN: 2379-3708 ;EISSN: 2379-3708 ;DOI: 10.1172/jci.insight.151463 ;PMID: 34665783

Full text available

Citations Cited by
8
Quadrivalent influenza nanoparticle vaccines induce broad protection
Quadrivalent influenza nanoparticle vaccines induce broad protection
Material Type:
Article 		Add to My Research

Quadrivalent influenza nanoparticle vaccines induce broad protection

Nature (London), 2021-04, Vol.592 (7855), p.623-628 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Apr 22, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03365-x ;PMID: 33762730

Full text available

Citations Cited by
9
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Material Type:
Article 		Add to My Research

Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2

Cell, 2020-11, Vol.183 (5), p.1367-1382.e17 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 The Authors 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.10.043 ;PMID: 33160446

Digital Resources/Online E-Resources

Citations Cited by
10
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Material Type:
Article 		Add to My Research

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

Cell, 2021-10, Vol.184 (21), p.5432-5447.e16 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.09.015 ;PMID: 34619077

Full text available

Citations Cited by
11
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses
Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses
Material Type:
Article 		Add to My Research

Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses

Immunity (Cambridge, Mass.), 2022-09, Vol.55 (9), p.1680-1692.e8 [Peer Reviewed Journal]

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2022.07.015 ;PMID: 35977542

Full text available

Citations Cited by
12
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Adjuvanting a subunit COVID-19 vaccine to induce protective immunity
Material Type:
Article 		Add to My Research

Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

Nature (London), 2021-06, Vol.594 (7862), p.253-258 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03530-2 ;PMID: 33873199

Full text available

Citations Cited by
13
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens
Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens
Material Type:
Article 		Add to My Research

Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens

Cell reports. Medicine, 2022-10, Vol.3 (10), p.100780, Article 100780 [Peer Reviewed Journal]

Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved. ;2022 The Author(s) 2022 ;ISSN: 2666-3791 ;EISSN: 2666-3791 ;DOI: 10.1016/j.xcrm.2022.100780 ;PMID: 36206752

Full text available

Citations Cited by
14
Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection
Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection
Material Type:
Article 		Add to My Research

Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection

The Journal of infectious diseases, 2020-09 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. ;EISSN: 1537-6613 ;PMID: 33000143

Full text available

Citations Cited by
15
Journey and Transformation: Visual narrative by Deleah Pettie
Journey and Transformation: Visual narrative by Deleah Pettie
Material Type:
Web Resources 		Add to My Research

Journey and Transformation: Visual narrative by Deleah Pettie

Digital Resources/Online E-Resources

Citations Cited by
16
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Material Type:
Article 		Add to My Research

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

bioRxiv, 2021-03

2021. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2021.03.15.435528

Digital Resources/Online E-Resources

Citations Cited by
17
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates
Material Type:
Article 		Add to My Research

Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primates

bioRxiv, 2021-02

2021. Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the associated terms available at https://www.biorxiv.org/content/10.1101/2021.02.10.430696v1 ;DOI: 10.1101/2021.02.10.430696

Digital Resources/Online E-Resources

Citations Cited by
18
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2
Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2
Material Type:
Article 		Add to My Research

Elicitation of potent neutralizing antibody responses by designed protein nanoparticle vaccines for SARS-CoV-2

bioRxiv, 2020-08

2020. This article is published under http://creativecommons.org/licenses/by-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2020.08.11.247395

Digital Resources/Online E-Resources

Citations Cited by
19
Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines
Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines
Material Type:
Article 		Add to My Research

Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines

bioRxiv, 2020-05

2020. This article is published under https://creativecommons.org/publicdomain/zero/1.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1101/2020.05.30.125179

Digital Resources/Online E-Resources

Citations Cited by

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (14)

Refine My Results

Creation Date 

From To
Refine
  1. Before 2012  (1)
  2. 2012 To 2019  (1)
  3. 2020 To 2020  (6)
  4. 2021 To 2022  (11)
  5. After 2022  (1)
  6. More options open sub menu

Resource Type 

  1. Articles  (18)
  2. Web Resources  (1)
  3. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait